DYN
Price
$11.02
Change
+$0.24 (+2.23%)
Updated
Apr 24, 02:23 PM (EDT)
Capitalization
1.13B
7 days until earnings call
WINT
Price
$1.15
Change
+$0.02 (+1.77%)
Updated
Apr 24, 02:50 PM (EDT)
Capitalization
3.95M
Ad is loading...

DYN vs WINT

Header iconDYN vs WINT Comparison
Open Charts DYN vs WINTBanner chart's image
Dyne Therapeutics
Price$11.02
Change+$0.24 (+2.23%)
Volume$220
Capitalization1.13B
Windtree Therapeutics
Price$1.15
Change+$0.02 (+1.77%)
Volume$760
Capitalization3.95M
DYN vs WINT Comparison Chart
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. WINT commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Buy and WINT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (DYN: $10.78 vs. WINT: $1.11)
Brand notoriety: DYN and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 198% vs. WINT: 10%
Market capitalization -- DYN: $1.13B vs. WINT: $3.95M
DYN [@Biotechnology] is valued at $1.13B. WINT’s [@Biotechnology] market capitalization is $3.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, WINT is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while WINT’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 4 bearish.
  • WINT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, WINT is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а +37.68% price change this week, while WINT (@Biotechnology) price change was -1.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

WINT is expected to report earnings on Apr 15, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.13B) has a higher market cap than WINT($3.95M). DYN YTD gains are higher at: -54.244 vs. WINT (-93.644). WINT has higher annual earnings (EBITDA): -9.36M vs. DYN (-342.21M). DYN has more cash in the bank: 642M vs. WINT (917K). WINT has less debt than DYN: WINT (2.01M) vs DYN (24M). DYN (0) and WINT (0) have equivalent revenues.
DYNWINTDYN / WINT
Capitalization1.13B3.95M28,528%
EBITDA-342.21M-9.36M3,656%
Gain YTD-54.244-93.64458%
P/E RatioN/A0.83-
Revenue00-
Total Cash642M917K70,011%
Total Debt24M2.01M1,192%
FUNDAMENTALS RATINGS
WINT: Fundamental Ratings
WINT
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNWINT
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX39.26N/A
N/A
PGIM Quant Solutions Large-Cap Index A
FIFRX120.31N/A
N/A
Franklin Growth R6
MGLKX15.65N/A
N/A
MFS Global Real Estate R2
MLNCX20.80N/A
N/A
Morgan Stanley Instl Glbl Concntr C
WSACX24.79N/A
N/A
Wellington Shields All-Cap Instl

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+8.78%
CRNX - DYN
50%
Loosely correlated
+3.55%
ROIV - DYN
48%
Loosely correlated
+2.98%
INZY - DYN
47%
Loosely correlated
-4.84%
RNA - DYN
47%
Loosely correlated
+4.18%
ERAS - DYN
47%
Loosely correlated
+2.90%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been loosely correlated with MLEC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if WINT jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
+1.83%
MLEC - WINT
49%
Loosely correlated
-9.65%
DVHGF - WINT
37%
Loosely correlated
N/A
INMB - WINT
31%
Poorly correlated
+5.23%
DYN - WINT
28%
Poorly correlated
+8.78%
CDTX - WINT
27%
Poorly correlated
-0.48%
More